Share ownership Celltrion, Inc.

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 2026-04-10			5-day change	1st Jan Change
199,700.00 ^KRW	-0.89%		+2.25%	+10.33%

Apr. 08	Nomura Adjusts Celltrion's Price Target to KRW270,000 From KRW240,000, Keeps at Buy	MT
Apr. 03	South Korean shares fall for second week on Middle East worries	RE

Share class: Celltrion, Inc.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	214,108,119	151,748,905 ( 70.87 %)	0	70.87 %

Major shareholders: Celltrion, Inc.

Name	Equities	%	Valuation
Jung-Jin Seo 30.81 %	71,195,305	30.81 %	11 804 M ₩
CELLTRION, INC. 3.103 %	7,170,560	3.103 %	1 189 M ₩
Sjunde AP-fonden 0.1544 %	356,717	0.1544 %	59 M ₩
State Street Global Advisors Ltd. 0.1444 %	333,580	0.1444 %	55 M ₩
Heon-Young Yoo 0.1183 %	273,419	0.1183 %	45 M ₩
Hyung-Ki Kim 0.0984 %	227,242	0.0984 %	38 M ₩
Wu-Sung Ki 0.0883 %	204,120	0.0883 %	34 M ₩
Jun Seong Park 0.0644 %	148,696	0.0644 %	25 M ₩
Storebrand Asset Management AS 0.0457 %	105,479	0.0457 %	17 M ₩
West Yorkshire Pension Fund 0.0346 %	79,840	0.0346 %	13 M ₩
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Individuals	31.51%
Celltrion, Inc.	3.1%
Institutional	0.53%
Unknown	64.86%

Based on 1000 largest holdings

Geographical origin of shareholders

Individuals	31.51%
South Korea	3.1%
United Kingdom	0.19%
Sweden	0.16%
Norway	0.05%
Ireland	0.03%
Netherlands	0.03%
France	0.01%
Singapore	0.01%
Switzerland	0.01%
New Zealand	0.01%
Luxembourg	0.01%
Japan	0.01%

Based on 1000 largest holdings

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Employees

2,680

Sector

Biotechnology & Medical Research

More about the company